Expression of circulating microRNAs as predictors of diagnosis and surgical outcome in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
- 1 October 2020
- journal article
- research article
- Published by Elsevier BV in Epilepsy Research
- Vol. 166, 106373
- https://doi.org/10.1016/j.eplepsyres.2020.106373
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- MicroRNAs as biomarkers for CNS diseaseFrontiers in Molecular Neuroscience, 2013
- Hippocampal sclerosis—Origins and imagingEpilepsia, 2012
- Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticusCell Death & Disease, 2010
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsyEpilepsy Research, 2007
- Prognostic Factors for the Surgery for Mesial Temporal Lobe Epilepsy: Longitudinal AnalysisEpilepsia, 2005
- Mesial Temporal Lobe Epilepsy with Hippocampal SclerosisEpilepsia, 2004